Indeed, vessel density in ovarian tumours increases with tumour progression and correlates with expression of VEGF receptor 2.12 However, many ovarian tumours are not responsive to anti-VEGFA therapies due to upregulation of alternative pathways. The gene discussed is VEGFA; the disease is ovarian neoplasm.